Fingolimod (Gilenya) eligibility extended by NHS England
Fingolimod can now be prescribed on the NHS in England for people who continue to have relapses despite taking beta interferon or glatiramer acetate and for people taking natalizumab who are at high risk of developing progressive multifocal leukoencephalopathy (PML).
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news